-+ 0.00%
-+ 0.00%
-+ 0.00%

REPLIMUNE GROUP - FDA TARGET ACTION DATE FOR RP1 BLA RESUBMISSION IS AUGUST 2, 2026

Reuters·07/30/2026 22:15:00

Please log in to view news